AKT1 and ovarian carcinoma: In ovarian cancer, the FGFR/PI3K/AKT pathway has been implicated in the development of cisplatin resistance induced by the GLT8D (glycosylotransferase 8 domain containing2) protein through the interaction with FGFR1 and the subsequent signaling activation [92].